About Immunai:
Immunai is an engineering-first platform company aiming to improve therapeutic decision-making throughout the drug discovery and development process. We are mapping the immune system at unprecedented scale and granularity and applying machine learning to this massive clinico-immune database, in order to generate novel insights into disease pathology for our partners - pharma companies and research institutes. We provide a comprehensive, end-to-end solution - from data generation and curation to therapeutics development, that continuously supports and validates the capabilities of our platform.
As drug development is becoming increasingly inefficient, our ultimate goal is to help bring breakthrough medicines to patients as quickly and successfully as possible.
Immunai is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
About the role:
In this role, you will focus on processing and annotating single-cell RNA-seq data, ensuring data quality, and supporting internal data consumers. You will collaborate with various teams to develop and test data processing pipelines and contribute to building internal references for cell type prediction.
Location: Prague, Czech Republic. Hybrid position (3+2 days/week model), must be based in Prague
*Applications for a fully-remote work will NOT be considered.
What will you do?
Required qualifications:
Desired personal traits:
*Please note that when you apply for a position at Immunai, your application will be processed via our recruitment platform Comeet. You can read more about how we process personal data here: https://www.immunai.com/privacy-policy/